Medicus Pharma Advances Teverelix Phase 2 FDA Strategy
Philadelphia, Pennsylvania, USA, April 6, 2026 Optimized Phase 2 Design Targets Faster Clinical Development In a strategic move to...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Philadelphia, Pennsylvania, USA, April 6, 2026 Optimized Phase 2 Design Targets Faster Clinical Development In a strategic move to...
Minneapolis, Minnesota, USA, April 6, 2026 Breakthrough Radiation Protection Without Operational Disruption In a significant advancement for interventional cardiology...
BOSTON, March 30, 2026 In a significant advancement for interventional cardiology and electrophysiology procedures, Haemonetics Corporation announced that the...
RUTHERFORD, N.J., March 27, 2026 GlucoTrack announced plans to submit an Investigational Device Exemption (IDE) application to the U.S....
Parsippany, New Jersey, USA | March 19, 2026 Embecta Corp. has announced a definitive agreement to acquire Owen Mumford...
Louisville, Colorado, USA | March 20, 2026 Biodesix Inc. has announced the publication of the largest lung nodule biomarker...
FORT MILL, S.C., March 6, 2026 Catheter Precision, Inc., a U.S.-based medical technology company specializing in cardiac electrophysiology innovations,...
Middle East Partnership Advances Neurostimulation Care – February 18, 2026 | Mont-Saint-Guibert, Belgium Nyxoah has signed a Memorandum of...
Boston, Massachusetts — February 6, 2026 Johnson & Johnson has presented early clinical outcomes from the OMNY AF Pilot...
Madrid | January 28, 2026 — Corify Care, a cardiovascular MedTech innovator, announced a major advancement in cardiac electrophysiology...
